Tekla Life Sciences Investors
Location
Massachusetts
Founded
2000-01-26
Website
Risk Signals
155 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Management Investment Offices, Open-End), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Tekla Life Sciences Investors
Live alerts from global media, monitored by Business Radar

2023-10-27 (businesswire.com)
Tekla Capital Management LLC Announces Closing of Transaction With abrdn
HQH, HQL, THQ, THW Tekla Capital Management LLC (Tekla) announced today that it has completed the sale of its advisory business to abrdn Inc. In addit
Read more2023-06-20 (yahoo.com)
Tekla Capital Management LLC Announces Proposed Transaction
BOSTON, June 20, 2023--Tekla Capital Management LLC (Tekla) announced today that it has entered into an agreement with abrdn Inc. for a strategic transaction involving four NYSE-listed healthcare & biotech thematic closed-end funds (the Funds), totaling $3.1 bn in assets under management.1
Read more2023-06-20 (yahoo.com)
Tekla Capital Management LLC Announces Proposed Transaction
BOSTON, June 20, 2023--Tekla Capital Management LLC (Tekla) announced today that it has entered into an agreement with abrdn Inc. for a strategic transaction involving four NYSE-listed healthcare & biotech thematic closed-end funds (the Funds), totaling $3.1 bn in assets under management.1
Read more2023-06-20 (yahoo.com)
Tekla Capital Management LLC Announces Proposed Transaction
BOSTON, June 20, 2023--Tekla Capital Management LLC (Tekla) announced today that it has entered into an agreement with abrdn Inc. for a strategic transaction involving four NYSE-listed healthcare & biotech thematic closed-end funds (the Funds), totaling $3.1 bn in assets under management.1
Read more
(morningstar.com)
Tekla Funds Urge Shareholders to Vote Immediately to Guarantee Reduced Fund Expenses
Tekla Life Sciences Investors( HQL) announced at the Joint Special Meetings of shareholders(“
Read more